Lightcast Discovery

About:

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

Website: http://www.lightcast.bio

Top Investors: M Ventures, +ND Capital, Illumina Ventures, ARCH Venture Partners, Longwall Venture

Description:

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products. The company's mission is to push the boundaries of complex cell analysis. Using the Lightcast platform, the company is working with major pharmaceutical companies and leading academic institutes to enable them to discover more. The Lightcast platform allows precise and highly flexible independent control of thousands of droplets. By combining droplets containing different cells, reporters or other reagents we can perform complex workflows without the need to manipulate cells by hand. Lightcast Discovery was founded in 2019 by Cameron Frayling.